Compare Revvity Inc (RVTY) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Invesco S&P 500 High Div Low Volatility ETF trades at $52.18. The key difference: Revvity Inc pays a 0.26% dividend while Invesco S&P 500 High Div Low Volatility ETF pays none. Which is the better fit depends on your goals.
| RVTY | SPHD | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | — |
52-Week High | $117.75 | $53.18 |
52-Week Low | $82.26 | $46.96 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.
The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.
SPHD trades at $52.39, down 0.91% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering a 4.5% yield with monthly distributions. Recent news highlights its defensive appeal for retirees seeking stable income amid market uncertainty, though it has underperformed the broader S&P 500 historically.
Outlook remains cautious; SPHD provides income stability but faces growth limitations. Risks include interest rate sensitivity and sector concentration. Analyst sentiment is mixed, with upgrades citing defensive positioning but noting long-term performance gaps versus the market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
